Target intelligence / Profile preview

Gamma-1-syntrophin (SNTG1)

Target
SNTG1
Molecular classification
Other (cytoplasmic peripheral membrane protein, adapter protein)
01

Overview

Gamma-1-syntrophin is a cytoplasmic peripheral membrane adapter protein encoded by the human SNTG1 gene on chromosome 8. It contains two pleckstrin homology (PH) domains, a PDZ domain, and a C-terminal domain that can bind dystrophin. SNTG1 is expressed predominantly in the brain and is important for organizing the subcellular localization of various proteins, often by linking receptors to cellular structural frameworks such as the actin cytoskeleton and dystrophin glycoprotein complex. Additionally, it plays a role in regulating the positioning and inactivation of molecules like diacylglycerol kinase-zeta following receptor activation and is involved in trafficking gamma-enolase to the plasma membrane to enhance neurotrophic activity. Genetic variants and abnormalities in SNTG1 have been associated with several neurological and autoimmune diseases, but SNTG1 is not presently considered a direct therapeutic target such as a receptor, enzyme, or transporter[1][2][3][7][8].

Other names
G1SYNSYN4syntrophin gamma 1syntrophin-4gamma1-syntrophinsyntrophin 4
02

Biological functions

Adapter protein function (organizes subcellular localization of proteins)Links receptors to the actin cytoskeleton and dystrophin glycoprotein complexRegulates placement of diacylglycerol kinase-zeta for rapid diacylglycerol inactivation after receptor activationMediates gamma-enolase trafficking to plasma membrane and enhances its neurotrophic activity[1][2][7][8]
03

Disease associations

Substance abuseMultiple sclerosisAlzheimer’s diseaseParkinson’s diseaseLysosomal storage diseaseSystemic lupus erythematosusCryopyrin-associated periodic syndromeIdiopathic scoliosis

Beyond the preview

Go deeper on Gamma-1-syntrophin (SNTG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-1-syntrophin (SNTG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call